Navigation Links
Pharmos Corporation Reports 2008 Second Quarter Results
Date:8/7/2008

ISELIN, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Pharmos Corporation (Nasdaq: PARS) today reported results for the second quarter ended June 30, 2008. The Company recorded a net loss of $2.7 million, or $0.10 per share, for the second quarter 2008 compared to a net loss of $4.6 million, or $0.18 per share, in the second quarter 2007. Cash and cash equivalents totaled $9.0 million at June 30, 2008.

The decrease in net loss for the second quarter 2008 is due primarily to a 46% decrease in operating expenses to $2.6 million from $4.9 million in the second quarter 2007. The decline in operating expenses resulted from a 41% decrease in gross research and development expenses to $2.1 million compared to $3.7 million in the second quarter 2007. Also general and administrative expenses decreased 66% to $0.5 million from $1.3 million in the second quarter 2007.

During the second quarter, the Company advanced a Phase IIb trial of its lead compound, dextofisopam, in female IBS patients. The Phase IIb trial is expected to enroll approximately 480 patients in about 70 sites in the United States. Costs of $1,470,000 were incurred during the quarter in connection with the trial, comprising CRO-related activities and patient recruitment costs. During the second quarter, the Company engaged a second CRO to identify and manage additional sites. As the Company is currently behind its planned enrollment schedule, additional expenses were incurred in conducting a centralized advertising campaign to enhance patient enrollment. Dextofisopam was one of the compounds the Company obtained through the acquisition of Vela Pharmaceuticals Inc which closed in October 2006. The continued development of this compound through late-stage clinical testing will
'/>"/>

SOURCE Pharmos Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Pharmos Corporation to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
2. Pharmos Corporation Reports 2008 First Quarter Results
3. Pharmos Corporation Completes Initial Closing of Private Placement
4. Pharmos Corporation Announces Board and Management Changes
5. Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
6. Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference
7. Pharmos Corporation Reports 2007 Third Quarter Results
8. Pharmos Issues Letter to Shareholders
9. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
10. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO); $3.57 Price Target
11. PolyOne Corporation Announces an Exclusive License Agreement with Battelle for Bio-Plasticizer Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... NEW YORK , Dec. 24, 2014 ... advancing patient care in critical areas, announced the closing ... common stock, and warrants to purchase up to an ... price of $4.00 per share and $.01 per warrant.  ... $5.00, are exercisable immediately, and expire 5 years from ...
(Date:12/24/2014)... Missouri (PRWEB) December 23, 2014 GMO ... Swiss biotechnology company, Syngenta, are in the process of ... proceedings. The consolidated case is In Re: Syngenta AG ... U.S. District Court for the District of Kansas. , ... has been handed over to U.S. District Judge John ...
(Date:12/24/2014)... December 23, 2014 According to Ross Selinger, ... Affiliate of ITRA Global, the national office market continues to ... This is evidenced by the third quarter’s surprising 3.9% ... Low energy costs have held inflation down and the ... is the housing market remaining soft. , This solid economic ...
(Date:12/24/2014)... CA (PRWEB) December 23, 2014 Pipette.com ... where their Twitter followers can submit their #HolidayInTheLab pictures ... and their lab mates. , For those struggling to ... mates, the Pipette.com Holiday in the Lab Contest provides ... Pipette.com Twitter followers to send pictures of their ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2
... profound implications for nanoelectronic components. Researchers from the Nano-Science ... in collaboration with Japanese researchers, have shown how electrons ... between their motion and their attached magnetic field ... unprecedented control over the spin of electrons and may ...
... 21, 2011 Leading organizations understand the value of ... operational tactics across numerous functions. As pharmaceutical, biotechnology and ... must also evolve and develop new capabilities while refining ... " The Future of Market Research: Challenges ...
... Electronics researchers love graphene. A two-dimensional sheet of carbon ... electrons, which rocket through the material with 100 times ... devices will be challenging, say researchers at the National ... show that layering graphene on a substrate transforms its ...
Cached Biology Technology:Curved carbon for electronics of the future 2Role of Market Research Evolving to Take on a More Strategic Responsibility 2Real-world graphene devices may have a bumpy ride 2
(Date:12/19/2014)... 2014 Research and Markets ( ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... in July 2012, Apple introduced the fingerprint reading ... the only device of Apple incorporating such a ...
(Date:12/17/2014)... Va. , Dec. 15, 2014 ... to make it easier to detect and prevent ... Today the agency started performing an ... capability will validate the authenticity of purchased microcircuits ... The new quality control measures will be conducted ...
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... The discrimination that obese people feel, whether it is ... in the workplace, may have a direct impact on ... University. "Obesity is a physiological issue, but when ... sense of being discriminated againstit can make matters worse ...
... study of 45-million-year-old pollen from Pine Island west of Fort ... geologic history, showing Florida could be 10 million to 15 ... land in Florida during the early Eocene opens the possibility ... that time, including their adaptation, evolution and dispersal until the ...
... Indiana Jones as they search for plants in remote ... of life-saving new medicines, are currently trying to figure ... affect their work. That,s the topic of an article ... C&EN Associate Editor Carmen Drahl explains that ...
Cached Biology News:Stigma weighs heavily on obese people, contributing to greater health problems 2UF Pine lsland pollen study leads to revision of state's ancient geography 2UF Pine lsland pollen study leads to revision of state's ancient geography 3
The filter 695RDF55 Reflect 635 for the Molecular Imager FX is a band pass filter for Cy5 and Alexa Fluor 635 dyes....
... Kit is a 2-color staining method for ... to detect apoptotic cells by flow cytometry. ... required for measuring apoptosis in cells, including ... reagent performance; washing, reaction and rinsing buffers ...
The sample holders for gels are used to hold gels in place in the multi-sample tray I, which is used with Molecular Imager FX imaging systems....
... The ApopTag Fluorescein In Situ ... in situ by the indirect TUNEL ... is conjugated to a Fluorescein reporter ... for 40 samples. Results are analyzed ...
Biology Products: